Hidradenitis Suppurativa (HS)
Definition
Hidradenitis Suppurativa (HS) is a chronic, debilitating skin disorder that significantly affects quality of life, predominantly manifesting in young adults. It is characterized by the formation of painful nodules in intertriginous areas such as the axillae and groin. These lesions result from inflammation of apocrine sweat glands and often lead to disfiguring scars.
HS is non-contagious and is frequently diagnosed years or even decades after onset. Also known as “inverse acne,” it is commonly misdiagnosed as acne due to overlapping clinical features. The condition begins with follicular occlusion and subsequent inflammation, progressing to painful abscesses, sinus tract formation, and extensive subcutaneous fibrosis.
- Specialized Expertise and Long-Term Medical Training
- Comprehensive and Effective Treatment Approaches
- Maximum Therapeutic Efficacy
Minimal Side Effects
Clinical Presentation
HS typically presents with erythematous, tender, and painful nodules that may evolve into abscesses. These abscesses often drain purulent or serosanguinous fluid through the skin. Recurrent episodes can lead to the development of multiple sinus tracts and fibrotic scars.
If left untreated, the disease may worsen, resulting in painful abscesses that discharge blood and pus. As the lesions heal, they frequently leave hypertrophic or atrophic scars. Additional abscesses may form in the same or nearby areas.
Diagnosis
Early diagnosis and intervention can reduce recurrence rates and prevent progression to severe disease. Due to its similarity to acne, HS is often underdiagnosed or misdiagnosed. Patients typically report recurrent nodules, cysts, or sores in areas such as the axillae, buttocks, thighs, or groin.
Diagnosis is based on clinical features and is classified using the Hurley staging system:
- Stage I: Single or multiple abscesses without sinus tract formation or scarring; localized involvement.
- Stage II: Recurrent abscesses with sinus tract formation and scarring, with areas of healthy skin in between.
- Stage III: Diffuse or near-total involvement with multiple interconnected sinus tracts and widespread inflammation.
HS located in the perianal region must be differentiated from perirectal fistulas, as HS affects only the skin. A known association exists between HS and Crohn’s disease, and colonoscopy may be warranted in patients presenting with gastrointestinal symptoms.
Treatment
Managing Hidradenitis Suppurativa requires a multidisciplinary approach involving dermatologists and, in advanced cases, surgeons due to the high recurrence rates. The main therapeutic strategies include:
Lifestyle Modifications
- Smoking cessation
- Control of hyperhidrosis
- Maintenance of healthy body weight
These measures can significantly reduce disease flares.
Pharmacologic Therapy
For mild cases, initial treatment may include:
- Topical antibiotics (e.g., clindamycin)
- Corticosteroids
- Antiseptic cleansers
- Warm compresses
In moderate to severe cases, treatment escalation may involve:
- Combination antibiotic therapy (e.g., tetracyclines with clindamycin and rifampin)
- Oral retinoids and anti-inflammatory agents during flares
- Biologic agents, administered as subcutaneous injections, which induce long-term remission with fewer side effects than long-term antibiotic use
Specific biologics include:
- Adalimumab: A TNF-α inhibitor that targets a key pro-inflammatory mediator in HS.
- Secukinumab: An IL-17A inhibitor.
- Bimekizumab: The first and only approved biologic that selectively blocks both IL-17A and IL-17F, two cytokines central to HS pathogenesis.
Emerging therapies include:
- JAK inhibitors such as upadacitinib, tofacitinib, and ruxolitinib, which are being investigated as promising options for moderate to severe, treatment-resistant cases.
Surgical Intervention
Surgical procedures are considered for patients with chronic lesions, extensive sinus tracts, or persistent nodules. Options include:
- Surgical debridement
- Laser-assisted cauterization
- Wide excision in advanced stages
Laser hair removal in high-risk areas (e.g., axillae, pubic region, thighs) reduces local irritation and microbial contamination, thereby lowering the risk of new lesions or flare-ups.
Individualized Care & Prognosis
Personalized treatment protocols significantly improve symptom control and quality of life. Patients with HS are at increased risk for associated comorbidities such as arthritis, diabetes mellitus, and cardiovascular disease, warranting multidisciplinary care.
Scientific advancements have greatly improved our understanding and management of HS. While it remains a chronic and painful condition, early diagnosis and appropriately tailored therapy can effectively control disease activity, prevent new flare-ups, and treat existing inflammatory lesions.